Using the APOE4 Gene to Determine Alzheimer's Care

COMMENTARY

Using the APOE4 Gene to Determine Alzheimer's Care

Richard S. Isaacson, MD

Disclosures

December 11, 2018

0

Hello. I'm Dr Richard Isaacson, director of the Alzheimer's Prevention Clinic at Weill Cornell Medicine and NewYork-Presbyterian in New York City.

Is it time to start using the apolipoprotein ε4 (APOE4) gene tests to better inform our clinical practice? A new review paper[1] in the Journal of the Prevention of Alzheimer's Disease, by Berkowitz, [myself], and colleagues, talks about how the presence or lack of the APOE4 gene may help to better personalize or guide risk-reduction care for Alzheimer's disease. This field is complicated, which is why this paper is so useful for establishing what the data show.

Studies such as the FINGER trial[2] have shown that a multimodal lifestyle intervention including exercise, nutrition, and cognitive stimulation, in addition to regular follow-up visits with a treating physician or nurse practitioner, can actually have robust effects regardless of whether you have the APOE4 gene or not.

However, the question remains as to whether knowledge is power when it comes to knowing whether a person does have the APOE4 gene. I do think this is the case, not just for the physician but potentially also for the patient. For example, research has shown that physical activity may be even more important when looked at in isolation for people with the

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....